Prestige Consumer Healthcare Inc (NYSE:PBH) – Jefferies Financial Group upped their Q1 2020 earnings estimates for Prestige Consumer Healthcare in a note issued to investors on Tuesday, June 25th, according to Zacks Investment Research. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $0.65 per share for the quarter, up from their prior forecast of $0.61. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q3 2020 earnings at $0.78 EPS.
Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.67%. The business had revenue of $241.03 million during the quarter, compared to analysts’ expectations of $237.22 million. During the same quarter in the previous year, the firm earned $0.62 EPS. The firm’s revenue was down 5.8% compared to the same quarter last year.
PBH has been the subject of several other research reports. TheStreet cut USD Partners from a “b-” rating to a “c+” rating in a research report on Friday, May 10th. ValuEngine cut Intersect ENT from a “buy” rating to a “hold” rating in a research report on Monday, July 8th. Zacks Investment Research cut Hanger from a “hold” rating to a “sell” rating in a research report on Tuesday, May 28th. Royal Bank of Canada reissued a “buy” rating and set a $97.00 price objective on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. Finally, CIBC reaffirmed a “hold” rating and issued a $84.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, May 27th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. Prestige Consumer Healthcare presently has a consensus rating of “Hold” and a consensus target price of $57.77.
NYSE PBH opened at $30.96 on Friday. Prestige Consumer Healthcare has a twelve month low of $26.25 and a twelve month high of $41.76. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The firm has a market cap of $1.59 billion, a PE ratio of 11.14, a PEG ratio of 1.76 and a beta of 0.93. The business’s 50-day simple moving average is $30.68.
A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. raised its holdings in Prestige Consumer Healthcare by 4.0% in the 4th quarter. BlackRock Inc. now owns 6,457,359 shares of the company’s stock valued at $199,402,000 after acquiring an additional 248,243 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Prestige Consumer Healthcare by 11.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,049,957 shares of the company’s stock valued at $125,062,000 after acquiring an additional 420,265 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Prestige Consumer Healthcare by 3.2% in the 1st quarter. Wells Fargo & Company MN now owns 2,299,827 shares of the company’s stock valued at $68,788,000 after acquiring an additional 71,275 shares in the last quarter. Champlain Investment Partners LLC raised its holdings in Prestige Consumer Healthcare by 2.2% in the 1st quarter. Champlain Investment Partners LLC now owns 2,088,940 shares of the company’s stock valued at $62,480,000 after acquiring an additional 44,975 shares in the last quarter. Finally, Macquarie Group Ltd. raised its holdings in Prestige Consumer Healthcare by 17.6% in the 4th quarter. Macquarie Group Ltd. now owns 1,446,325 shares of the company’s stock valued at $44,663,000 after acquiring an additional 216,570 shares in the last quarter.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.